BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 29211304)

  • 1. Risk of recurrence, prognosis, and follow-up for Danish women with cervical cancer in 2005-2013: A national cohort study.
    Taarnhøj GA; Christensen IJ; Lajer H; Fuglsang K; Jeppesen MM; Kahr HS; Høgdall C
    Cancer; 2018 Mar; 124(5):943-951. PubMed ID: 29211304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
    Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
    Singh P; Tripcony L; Nicklin J
    Int J Gynecol Cancer; 2012 Jan; 22(1):115-22. PubMed ID: 21997176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of recurrence and prognosis in locally advanced FIGO stage IB2 to IIB cervical cancer: Retrospective multicentre study from the FRANCOGYN group.
    de Foucher T; Bendifallah S; Ouldamer L; Bricou A; Lavoue V; Varinot J; Canlorbe G; Carcopino X; Raimond E; Monnier L; Graesslin O; Touboul C; Collinet P; Neveu ME; Huchon C; Daraï E; Ballester M;
    Eur J Surg Oncol; 2019 Apr; 45(4):659-665. PubMed ID: 30685326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DLL4 as a predictor of pelvic lymph node metastasis and a novel prognostic biomarker in patients with early-stage cervical cancer.
    Yang S; Liu Y; Xia B; Deng J; Liu T; Li Q; Yang Y; Wang Y; Ning X; Zhang Y; Xiao M
    Tumour Biol; 2016 Apr; 37(4):5063-74. PubMed ID: 26546434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Satellite lymphovascular space invasion: An independent risk factor in early stage cervical cancer.
    Pol FJ; Zusterzeel PL; van Ham MA; Kuijpers DA; Bulten J; Massuger LF
    Gynecol Oncol; 2015 Sep; 138(3):579-84. PubMed ID: 26126782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do FIGO stage IA and small (≤2 cm) IB1 cervical adenocarcinomas have a good prognosis and warrant less radical surgery?
    Al-Kalbani M; McVeigh G; Nagar H; McCluggage WG
    Int J Gynecol Cancer; 2012 Feb; 22(2):291-5. PubMed ID: 22080884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
    Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
    Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locoregional spread and survival of stage IIA1 versus stage IIA2 cervical cancer.
    Hongladaromp W; Tantipalakorn C; Charoenkwan K; Srisomboon J
    Asian Pac J Cancer Prev; 2014; 15(2):887-90. PubMed ID: 24568513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of semiquantitative evaluation of lympho-vascular space invasion in early stage cervical cancer patients.
    Ronsini C; Anchora LP; Restaino S; Fedele C; Arciuolo D; Teodorico E; Bizzarri N; Zannoni GF; Ferrandina G; Scambia G; Fanfani F
    Gynecol Oncol; 2021 Aug; 162(2):299-307. PubMed ID: 34116834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study.
    Ørtoft G; Lausten-Thomsen L; Høgdall C; Hansen ES; Dueholm M
    J Gynecol Oncol; 2019 Sep; 30(5):e84. PubMed ID: 31328462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safe criteria for less radical trachelectomy in patients with early-stage cervical cancer: a multicenter clinicopathologic study.
    Kim HS; Choi CH; Lim MC; Chang SJ; Kim YB; Kim MA; Kim TJ; Park SY; Kim BG; Song YS; Bae DS; Kim JW
    Ann Surg Oncol; 2012 Jun; 19(6):1973-9. PubMed ID: 22183162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer.
    Weinberg LE; Kunos CA; Zanotti KM
    Int J Gynecol Cancer; 2013 Oct; 23(8):1438-45. PubMed ID: 24257558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lacunae in International Federation of Gynecology and Obstetrics (FIGO) classification for cervical carcinoma: observational study using TNM classification as comparator.
    Meva J; Chaudhary RK; Bhaduri D; Bhatia M; Hatti S; Ba R
    Int J Gynecol Cancer; 2013 Jul; 23(6):1071-7. PubMed ID: 23792602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors and patterns of recurrence in lymphovascular space invasion positive women with stage IIIC endometriod endometrial cancer.
    Cuylan ZF; Oz M; Ozkan NT; Comert GK; Sahin H; Turan T; Akbayir O; Kuscu E; Celik H; Dede M; Gungor T; Meydanli MM; Ayhan A
    J Obstet Gynaecol Res; 2018 Jun; 44(6):1140-1149. PubMed ID: 29516573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after a nationwide adoption of robotic minimally invasive surgery for early-stage cervical cancer - A population-based study.
    Jensen PT; Schnack TH; Frøding LP; Bjørn SF; Lajer H; Markauskas A; Jochumsen KM; Fuglsang K; Dinesen J; Søgaard CH; Søgaard-Andersen E; Jensen MM; Knudsen A; Øster LH; Høgdall C
    Eur J Cancer; 2020 Mar; 128():47-56. PubMed ID: 32109850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral lymphatic vessel density and clinicopathologic features of patients with early-stage cervical cancer after radical hysterectomy.
    Zaganelli FL; Carvalho FM; Almeida BG; Bacchi CE; Goes JC; Calil MA; Baracat EC; Carvalho JP
    Int J Gynecol Cancer; 2010 Oct; 20(7):1225-31. PubMed ID: 21135594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a surgical-pathologic staging and scoring system for cervical cancer.
    Li S; Li X; Zhang Y; Zhou H; Tang F; Jia Y; Hu T; Sun H; Yang R; Chen Y; Cheng X; Lv W; Wu L; Zhou J; Wang S; Huang K; Wang L; Yao Y; Yang Q; Yang X; Zhang Q; Han X; Lin Z; Xing H; Qu P; Cai H; Song X; Tian X; Shen J; Xi L; Li K; Deng D; Wang H; Wang C; Wu M; Zhu T; Chen G; Gao Q; Wang S; Hu J; Kong B; Xie X; Ma D
    Oncotarget; 2016 Apr; 7(15):21054-63. PubMed ID: 27014971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.